123C4 is a potent and selective small molecule agonist targeting the EPHA4 receptor tyrosine kinase, with a competitive binding affinity (Ki=0.65 µM). It is a valuable research tool for studying EPHA4 signaling in neurological disorders and cancer, applicable in both cellular and biochemical assays.